What is LOPJLB’s current signal on SRZN?

LOPJLB’s latest quantitative signal on Surrozen, Inc. (SRZN) is BUY in a CRISIS regime. Signals are updated daily.

What market regime is SRZN in?

Surrozen, Inc. (SRZN) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Surrozen, Inc. (SRZN) do?

Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which …

Where is Surrozen, Inc. based / listed?

Surrozen, Inc. is based in US, listed on NASDAQ.

Surrozen, Inc. (SRZN)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$27.97+11.21%Close

BUYCRISIS · day 3

[SCORES & PROFILE]

FUND: 0
VALUE: 4
GROWTH: 11
GARP: 2
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC112.6%

REV YoY-

ROE187.6%

EPS YoY-

ROA-287.3%

GROSS

-385

NET

-2885

[VALUATION]

P/E TTM-0.64

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B-1.41

P/FCF-

EV/EBITDA-0.31

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO12.14

ND/EBITDA-

BETA0.56

Surrozen, Inc. (SRZN)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news